Ana Luísa Coelho, researcher of Algarve Biomedical Center Research Institute (ABC-RI) and lecturer at the School of Health of the University of Algarve, has just had the project “Identification of biomarkers and Predictive factors for Personalized metabolic surgery for the Treatment of Obesity (IMPPACTO)” approved by the Clinical Research and Biomedical Innovation Agency (AICIB), with a total funding of 26,845.56 euros.
The IMPPACTO project, submitted in partnership between the University Hospital Center of Algarve (CHUA) and the Algarve Biomedical Center (ABC), focuses on obesity and its surgical treatment, as well as sarcopenia, a condition characterized by a loss of muscle mass and strength that can coexist with obesity.
This three-year project aims to identify new biomarkers related to specific outcomes of the surgical procedure, which will be established as indicators of success. The ultimate goal is to advance towards a more personalized treatment for obesity, tailored to each individual.
The researcher from the University of Algarve is the co-investigator responsible for this project, which has now been awarded by AICIB, with support from the solidarity account “Todos Por Quem Cuida” (TPQC), highlighting relevant research in the field of aging.
The award ceremony took place on December 13th at the Order of Physicians in Lisbon.